[1]
“USE OF BIOGENIC PEPTIDES IN COMPLEX TREATMENT OF INFLAMMATORY DISEASES OF PARODONT IN PATIENTS WITH DIABETES MELLITUS II TYPE”, JournalNX, vol. 7, no. 04, pp. 168–169, Apr. 2021, Accessed: Oct. 31, 2025. [Online]. Available: https://repo.journalnx.com/index.php/nx/article/view/3065